The patients showed a significant increase in the levels of inflammatory markers IL-1β (p < 0.001), TNF-α (p < 0.001), and CRP (p < 0.001), despite improvement in PTSD (p < 0.001) and depression (p < 0.001) symptoms from baseline through one year follow-up. The gene discussed is IL1B; the disease is major depressive disorder.